Leprosy Diagnostic Working Group
The Leprosy Diagnostic Working Group is fostering the development of a target product profile (TPP) for a leprosy diagnostic by bringing together experts in laboratory science, experts in the clinical aspects of leprosy, and representatives from stakeholder groups in the leprosy community. Dr. Sundeep and Dr. Petra co-chair this working group. See the list of members.
Country Modeling Working Group
The Country Modeling Working Group provides feedback on GPZL’s mathematical modeling project. Modeling expert David Blok is building compelling tools for advocacy and fundraising. The Country Modeling Working Group, which includes country representatives, partners involved in resource mobilization, and GPZL Leadership Team Members, offers guidance and context to David Blok throughout the modeling project. See the list of members.
COVID-19 Response Working Groups
In response to the COVID-19 pandemic, the Partnership has formed three emergency response working groups:
Working Group 1: Leprosy Emergency Operations Committee (LEOC)
The LEOC is chaired by Ms. Arielle Cavaliero (Novartis) and Dr. Benedict Quao (Leprosy Program Manager, Ghana), and includes WHO’s Global Leprosy Program and others working directly in the supply chain for multi-drug therapy (MDT). This group is addressing and resolving issues in the supply of drugs for the treatment of leprosy and leprosy reactions, and other forms of care such as wound care, disability care, and social care, and supporting the work of National Leprosy Programmes.
Working Group 2: Emergency Advocacy for Persons Affected
The Emergency Advocacy for Persons Affected Working Group is chaired by Dr. Alice Cruz (U.N. Rapporteur for Persons Affected and their Families) and Mr. Amar Timulsina (President of IDEA Nepal). This working group is spearheading a global advocacy campaign so that no patients are left behind. This group is working with persons affected to gather information on their needs during the pandemic and share information about government and NGO responses to those needs.
Working Group 3: Post COVID-19
The Post COVID-19 Working Group is chaired by Mr. Geoff Warne (ILEP CEO) and Dr. Takahiro Nanri (Executive Director, Sasakawa Health Foundation). This group is thinking critically about future health scenarios and developing a path forward for the leprosy community in a post-COVID world.
Together, these working groups lead action by the leprosy community to protect leprosy prevention and control gains, to support persons affected, and to set a path toward zero leprosy. Sign up for our newsletter to stay updated on their work.
Read more about the Partnership’s foundational working groups, operational from 2018-2019: the Research Agenda Working Group, the Operational Excellence Working Group, and the Partnership and Resource Mobilization Working Group.